Cerespir   Report issue

For profit Phase 1 Phase 2
Founded: New York NY United States (2013)
Status: Defunct (2021)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

CERESPIR

Active Ingredients

Drugs in Phase 2 Trials (1)

chf5074 (5 trials)

Drugs in Phase 1 Trials (1)

chf 5974 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 2)

Cognitive Dysfunction (Phase 2)

Nerve Degeneration (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 5
  • # of Trial APIs: 2